跳至主要内容
临床试验/EUCTR2007-006268-32-IT
EUCTR2007-006268-32-IT进行中(未招募)不适用

EFFICACY AND SAFETYOF BOTULINUM TOXIN THERAPY ON UPPER LIMB SPASTICITY IN INFLAMMATORY AND DEMIELINIZZATING DISEASE OF CENTRAL NERVOUS SYSTEM. - ND

OSPEDALE S. RAFFAELE0 个研究点开始时间: 2007年11月23日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • patients aged more then 18 affected by primary or secondary progressive SM or by other chronic inflammatory diseases of the CNS diagnosed 6 months before the beginning of the study;arm spasticity with 1 or more point for Modified Ashworth Scale ; ...........
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • permanent contractures or severe atrophy in spastic arm; previous treatment with BT-A or with alccol/phenol injection or surgery;modification in madical therapy or rehabilitation therapy in the prevoious 3 months; treatment with intratecal baclofen or with drugs modulationg neuromuscolar trasmission; .......

研究者

发起方
OSPEDALE S. RAFFAELE

相似试验

EFFICACY AND SAFETYOF BOTULINUM TOXIN THERAPY ON... | 临床试验